Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?

The limited impact of treatments for COVID-19 has stimulated several Phase 1 clinical trials of whole-lung low-dose radiation therapy (LDRT; 0.3 – 1.5 Gy) that are now proceeding to Phase 2 randomized trials worldwide. This novel but unconventional use of radiation to treat COVID-19 prompted the Nat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Res
Autori principali: Prasanna, Pataje G., Woloschak, Gayle E., DiCarlo, Andrea L., Buchsbaum, Jeffrey C., Schaue, Dörthe, Chakravarti, Arnab, Cucinotta, Francis A., Formenti, Silvia C., Guha, Chandan, Hu, Dale J., Khan, Mohammad K., Kirsch, David G., Krishnan, Sunil, Leitner, Wolfgang W., Marples, Brian, McBride, William, Mehta, Minesh P., Rafii, Shahin, Sharon, Elad, Sullivan, Julie M., Weichselbaum, Ralph R., Ahmed, Mansoor M., Vikram, Bhadrasain, Coleman, C. Norman, Held, Kathryn D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009137/
https://ncbi.nlm.nih.gov/pubmed/33045077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RADE-20-00211.1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi